NR1H3 and atherosclerosis: FXR, encoded by NR1H3, is a nuclear receptor primarily expressed in the liver and intestines, where it regulates bile acid, lipid, and glucose metabolism.[29] By modulating genes involved in lipid metabolism, FXR reduces lipid deposition and the risk of atherosclerosis, which may indirectly influence the occurrence of AMI.